Erin Wright
Stock Analyst at Morgan Stanley
(4.85)
# 391
Out of 5,000 analysts
801
Total ratings
61.7%
Success rate
14.4%
Average return
Main Sectors:
Stocks Rated by Erin Wright
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PETS PetMed Express | Maintained: Sell | $2.15 | $1.61 | +33.54% | 24 | Sep 25, 2026 | |
| MCK McKesson | Rated: Buy | $977 | $874.65 | +11.70% | 30 | Sep 18, 2026 | |
| DGX Quest Diagnostics | Reiterated: Buy | $260 | $246.45 | +5.50% | 37 | Aug 19, 2026 | |
| CAH Cardinal Health | Reiterated: Buy | $255 | $225.38 | +13.14% | 32 | Aug 12, 2026 | |
| CVS CVS Health | Rated: Buy | $111 | $88.84 | +24.94% | 31 | Aug 10, 2026 | |
| ELAN Elanco Animal Health | Rated: Hold | $26 | $22.42 | +15.97% | 36 | Aug 10, 2026 | |
| ZTS Zoetis | Rated: Buy | $99 → $85 | $71.40 | +19.05% | 37 | Aug 10, 2026 | |
| COR Cencora | Rated: Buy | $342 → $346 | $308.78 | +12.05% | 30 | Aug 7, 2026 | |
| MDLN Medline | Reiterated: Buy | $52 → $48 | $31.64 | +51.71% | 2 | Aug 6, 2026 | |
| NVST Envista Holdings | Rated: Hold | $23 | $23.35 | -1.50% | 28 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | $249 → $370 | $386.22 | -4.20% | 22 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $805 | $511.65 | +57.33% | 37 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $80 | $56.78 | +40.89% | 20 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $361 | $275.28 | +31.14% | 19 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $308 → $338 | $320.71 | +5.39% | 35 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $188 | $147.61 | +27.36% | 56 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $57 → $66 | $65.11 | +1.37% | 10 | Jul 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $167 | $200.79 | -16.83% | 10 | Jul 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $9.54 | - | 40 | Jul 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $404 | $410.95 | -1.69% | 13 | Jul 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $468 → $529 | $376.90 | +40.36% | 32 | Jul 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 → $28 | $24.30 | +15.23% | 5 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $64 | $84.84 | -24.56% | 30 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $45 → $49 | $34.56 | +41.78% | 30 | Feb 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $48 | $11.97 | n/a | 1 | Feb 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $24 → $26 | $100.55 | n/a | 9 | Jul 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $352 → $385 | $278.06 | n/a | 28 | Jul 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $245 → $250 | $164.11 | n/a | 28 | Jul 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $157 → $265 | $266.42 | n/a | 10 | Jul 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $181 → $205 | $612.33 | n/a | 13 | Jul 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $271 → $288 | $211.81 | n/a | 21 | Jun 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $121 | $20.62 | n/a | 11 | Jun 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $42 → $44 | $6.97 | n/a | 5 | May 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $49 → $55 | $21.69 | n/a | 11 | Mar 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $35 → $36 | $8.42 | n/a | 2 | Mar 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $556 → $580 | $651.45 | n/a | 7 | Jan 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $18 → $25 | $15.52 | n/a | 3 | Jul 29, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $14 → $13 | $0.8897 | n/a | 5 | May 10, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $43 | $205.04 | n/a | 1 | Mar 15, 2013 |
PetMed Express
Sep 25, 2026
Maintained: Sell
Price Target: $2.15
Current: $1.61
Upside: +33.54%
McKesson
Sep 18, 2026
Rated: Buy
Price Target: $977
Current: $874.65
Upside: +11.70%
Quest Diagnostics
Aug 19, 2026
Reiterated: Buy
Price Target: $260
Current: $246.45
Upside: +5.50%
Cardinal Health
Aug 12, 2026
Reiterated: Buy
Price Target: $255
Current: $225.38
Upside: +13.14%
CVS Health
Aug 10, 2026
Rated: Buy
Price Target: $111
Current: $88.84
Upside: +24.94%
Elanco Animal Health
Aug 10, 2026
Rated: Hold
Price Target: $26
Current: $22.42
Upside: +15.97%
Zoetis
Aug 10, 2026
Rated: Buy
Price Target: $99 → $85
Current: $71.40
Upside: +19.05%
Cencora
Aug 7, 2026
Rated: Buy
Price Target: $342 → $346
Current: $308.78
Upside: +12.05%
Medline
Aug 6, 2026
Reiterated: Buy
Price Target: $52 → $48
Current: $31.64
Upside: +51.71%
Envista Holdings
Aug 6, 2026
Rated: Hold
Price Target: $23
Current: $23.35
Upside: -1.50%
Aug 5, 2026
Upgraded: Hold
Price Target: $249 → $370
Current: $386.22
Upside: -4.20%
Aug 5, 2026
Reiterated: Buy
Price Target: $805
Current: $511.65
Upside: +57.33%
Aug 3, 2026
Rated: Buy
Price Target: $80
Current: $56.78
Upside: +40.89%
Jul 31, 2026
Reiterated: Buy
Price Target: $361
Current: $275.28
Upside: +31.14%
Jul 31, 2026
Reiterated: Buy
Price Target: $308 → $338
Current: $320.71
Upside: +5.39%
Jul 30, 2026
Reiterated: Hold
Price Target: $188
Current: $147.61
Upside: +27.36%
Jul 29, 2026
Reiterated: Hold
Price Target: $57 → $66
Current: $65.11
Upside: +1.37%
Jul 24, 2026
Rated: Hold
Price Target: $167
Current: $200.79
Upside: -16.83%
Jul 24, 2026
Reiterated: Hold
Price Target: n/a
Current: $9.54
Upside: -
Jul 17, 2026
Rated: Hold
Price Target: $404
Current: $410.95
Upside: -1.69%
Jul 17, 2026
Rated: Buy
Price Target: $468 → $529
Current: $376.90
Upside: +40.36%
May 6, 2026
Reiterated: Buy
Price Target: $28 → $28
Current: $24.30
Upside: +15.23%
May 5, 2026
Reiterated: Sell
Price Target: $64
Current: $84.84
Upside: -24.56%
Feb 6, 2026
Reiterated: Hold
Price Target: $45 → $49
Current: $34.56
Upside: +41.78%
Feb 9, 2023
Reiterated: Hold
Price Target: $48
Current: $11.97
Upside: n/a
Jul 28, 2021
Reiterated: Hold
Price Target: $24 → $26
Current: $100.55
Upside: n/a
Jul 20, 2021
Reiterated: Hold
Price Target: $352 → $385
Current: $278.06
Upside: n/a
Jul 20, 2021
Reiterated: Buy
Price Target: $245 → $250
Current: $164.11
Upside: n/a
Jul 20, 2021
Reiterated: Buy
Price Target: $157 → $265
Current: $266.42
Upside: n/a
Jul 20, 2021
Reiterated: Buy
Price Target: $181 → $205
Current: $612.33
Upside: n/a
Jun 18, 2021
Reiterated: Buy
Price Target: $271 → $288
Current: $211.81
Upside: n/a
Jun 9, 2021
Reiterated: Buy
Price Target: $121
Current: $20.62
Upside: n/a
May 11, 2021
Reiterated: Buy
Price Target: $42 → $44
Current: $6.97
Upside: n/a
Mar 16, 2021
Reiterated: Sell
Price Target: $49 → $55
Current: $21.69
Upside: n/a
Mar 5, 2021
Reiterated: Hold
Price Target: $35 → $36
Current: $8.42
Upside: n/a
Jan 12, 2021
Reiterated: Buy
Price Target: $556 → $580
Current: $651.45
Upside: n/a
Jul 29, 2020
Rated: Buy
Price Target: $18 → $25
Current: $15.52
Upside: n/a
May 10, 2018
Downgraded: Sell
Price Target: $14 → $13
Current: $0.8897
Upside: n/a
Mar 15, 2013
Reiterated: Buy
Price Target: $43
Current: $205.04
Upside: n/a